Turnover: 210 million (2022)
Country: Switzerland
- CARBOGEN AMCIS is a leading manufacturer of sterile IMPs based on complex compounds
- It offers a full range of services for the development of lyophilized and liquid formulations, as well as batch manufacturing for preclinical and clinical studies.
News
Carbogen Amcis: a new production site in the Puy-de-Dôme region of France 28/02/2023
- The Group provides drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development
- 210 million in sales by 2022
- Carbogen Amcis has over 600 employees, two sites in France, four in Switzerland, one in the Netherlands and one in China,